26B-5-211. Administration of opioid litigation proceeds — Requirements for governmental entities receiving opioid funds — Reporting.
| (1) |
As used in this section:
Terms Used In Utah Code 26B-5-211- Administrator: includes "executor" when the subject matter justifies the use. See Utah Code 68-3-12.5
- Contract: A legal written agreement that becomes binding when signed.
- Fiscal year: The fiscal year is the accounting period for the government. For the federal government, this begins on October 1 and ends on September 30. The fiscal year is designated by the calendar year in which it ends; for example, fiscal year 2006 begins on October 1, 2005 and ends on September 30, 2006.
- Litigation: A case, controversy, or lawsuit. Participants (plaintiffs and defendants) in lawsuits are called litigants.
- Office: means the Office of Substance Use and Mental Health created in Section 26B-5-102. See Utah Code 26B-5-101
- Person: means :Utah Code 68-3-12.5
- Settlement: Parties to a lawsuit resolve their difference without having a trial. Settlements often involve the payment of compensation by one party in satisfaction of the other party's claims.
- State: when applied to the different parts of the United States, includes a state, district, or territory of the United States. See Utah Code 68-3-12.5
| (a) |
“Office” means the Office of Substance Use and Mental Health within the department. |
| (b) |
“Opioid funds” means money received by the state or a political subdivision of the state as a result of any judgment, settlement, or compromise of claims pertaining to alleged violations of law related to the manufacture, marketing, distribution, or sale of opioids. |
| (c) |
“Restricted account” means the Opioid Litigation Proceeds Restricted Account created in Section 51-9-801. |
|
| (2) |
Opioid funds may not be used to:
| (a) |
reimburse expenditures that were incurred before the opioid funds were received by the governmental entity; or |
| (b) |
supplant or take the place of any funds that would otherwise have been expended for that purpose. |
|
| (3) |
The office shall serve as the reporting entity to receive, compile, and submit any reports related to opioid funds that are required by law, contract, or other agreement. |
| (4) |
The requirement described in Subsection (5) applies to:
| (a) |
a recipient of opioid funds from the restricted account, in any year that opioid funds are received; and |
| (b) |
a political subdivision that received opioid funds. |
|
| (5) |
A person described in Subsection (4) shall provide an annual report to the office, in a form and by a date established by the office, that includes:
| (a) |
an accounting of all opioid funds that were received by the person in the year; |
| (b) |
the number of individuals served through programs funded by the opioid funds, including the individuals’ age, gender, and other demographic factors reported in a de-identified manner; |
| (c) |
the measures that were used to determine whether the program funded by the opioid funds achieved the intended outcomes; and |
| (d) |
if applicable, any information required to be submitted to the reporting entity under applicable law, contract, or other agreement. |
|
| (6) |
Beginning October 1, 2023, and on or before October 1 of each year thereafter, the office shall provide a written report that includes:
| (a) |
the opening and closing balance of the restricted account for the previous fiscal year; |
| (b) |
the name of and amount received by each recipient of funds from the restricted account; |
| (c) |
a description of the intended use of each award, including the specific program, service, or resource funded, population served, and measures that the recipient used or will use to assess the impact of the award; |
| (d) |
a description of any finding or concern as to whether all opioid funds disbursed from the restricted account violated the prohibitions in Subsection (2) and, if applicable, complied with the requirements of a settlement agreement; and |
| (e) |
the performance indicators and progress toward improving outcomes and reducing mortality and other harms related to substance use disorders. |
|
| (7) |
The office shall provide the information that is received, compiled, and submitted under this section:
| (a) |
to the Health and Human Services Interim Committee; |
| (b) |
to the Social Services Appropriations Subcommittee; |
| (c) |
if required under the terms of a settlement agreement under which opioid funds are received, to the administrator of the settlement agreement in accordance with the terms of the settlement agreement; and |
| (d) |
in a publicly accessible location on the department’s website. |
|
Enacted by Chapter 319, 2023 General Session
Technically renumbered to avoid duplication of newly enacted Chapter also in SB 41, Chapter 308.
